Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome by Amrita Goyal, MD, Damodaran Narayanan, MBBS, PhD, Waihay Wong, MD, PhD, Alvaro C. Laga, MD, Nathan T. Connell, MD, MPH, Susan Y. Ritter, MD, PhD, Gabriela Cobos, MD

Get full text